BioSpace News Archive

Heron Therapeutics, Inc. (Nasdaq: HRTX) announced today the appointment of Ira Duarte as Chief Financial Officer.

Clario, a healthcare research technology company that delivers leading endpoint technology solutions for clinical trials, and the medical technology company Sleepiz AG announced today a strategic partnership to integrate novel sleep and respiratory parameters into clinical trials.

Nevro Corp. today announced that data from an analysis of the 24-Month SENZA Painful Diabetic Neuropathy (PDN) Randomized Controlled Trial (RCT), the largest RCT to evaluate spinal cord stimulation (SCS) to treat PDN, will be presented at the American Diabetes Association (ADA) 83rd Scientific Sessions to be held June 23-26, 2023 in San Diego, CA.

Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) on June 15, 2023 for patent application 17/568,999, “Abuse and Misuse Deterrent Transdermal Systems” which covers its Aversa™ abuse deterrent technology.

scPharmaceuticals Inc. today announced that it expects to be added to the small cap Russell 2000 ® and broad market Russell 3000 ® Indexes at the conclusion of the Russell US Indexes annual reconstitution, effective when the US market opens on June 26, 2023, according to a preliminary list of additions posted on May 19, 2023.

Regulus Therapeutics Inc. today announced Preston S. Klassen , M.D., President and Head of Research & Development, has been appointed to the Company’s Board of Directors.

Today, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced a partnership with point-of-care ultrasound innovator EchoNous, to enable more healthcare professionals to perform cardiac ultrasound and help increase patient access to cardiac care.

LUMINELLE, an innovative medical device company, announces a substantial marketing agreement with the U.S. Women’s Health Alliance, an organization focused on promoting high-quality, affordable healthcare for women.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a robust collection of new clinical and real-world data on the MiniMed™ 780G system.

Sciwind Biosciences Co., Ltd. today announced that the company will present positive results from clinical studies of ecnoglutide at the 83rd American Diabetes Association (ADA) conference.